Weill Cornell Medical College — COVID-19 Antiviral Studies (Ria Goswami)

Organization Name 
Award Date 
2/2021
Grant Amount 
$220,553
Purpose 
To study the effectiveness of an Hsp90 protein inhibitor as a host-directed antiviral against the COVID-19 virus.
Topic (focus area) 

Grant Investigators: Heather Youngs and Chris Somerville

This page was reviewed but not written by the grant investigators. Weill Cornell Medical College staff also reviewed this page prior to publication.

Open Philanthropy recommended a grant of $220,553 to the Weill Cornell Medical College of Cornell University to enable postdoctoral researcher Ria Goswami and Dr. Sallie Permar to collaborate with researchers at Duke University and UC Davis to study the effectiveness of an Hsp90 protein inhibitor as a host-directed antiviral against the COVID-19 virus.

This follows our May 2020 support for earlier phases of the study at Duke University and falls within our work on scientific research, specifically within our interest in science supporting biosecurity and pandemic preparedness.